carbidopa has been researched along with Sensitivity and Specificity in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (15.00) | 18.2507 |
| 2000's | 6 (30.00) | 29.6817 |
| 2010's | 10 (50.00) | 24.3611 |
| 2020's | 1 (5.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Ayala, A; Forjaz, MJ; Harmat, M; Janszky, J; Juhász, A; Kovács, N; Martinez-Martin, P; Pintér, D; Rodriguez-Blazquez, C | 1 |
| Bakhtiar, R; Bronsema, KJ; Gorman, SH; van de Merbel, NC | 1 |
| Holiga, Š; Jech, R; Möller, HE; Mueller, K; Růžička, E; Schroeter, ML; Sieger, T; Vymazal, J | 1 |
| de Vries, EF; Di Gialleonardo, V; Dierckx, RA; Kema, IP; Ramakrishnan, NK; van Waarde, A; Visser, AK; Willemsen, AT | 1 |
| Cardoso, MA; de Carvalho, KA; Marson, BM; Pontarolo, R; Pontes, FL; Ribeiro, RP; Vilhena, Rde O | 1 |
| Faridbod, F; Ganjali, MR; Hosseini, M; Mirzanasiri, N; Norouzi, P; Rezapour, M; Sheikhha, MH | 1 |
| Alexiou, A; Psiha, M; Vlamos, P | 1 |
| Boisson, F; Brasse, D; Detour, J; Imperiale, A; Kessler, L; Kreutter, G; Lavaux, T; Marchand, P; Namer, IJ; Pierre, A | 1 |
| Karim, MM; Kim, WH; Lee, SH | 1 |
| Kroenke, K; Murck, H; Stacy, MA | 1 |
| Bonfim, RR; Byrro, RM; César, IC; Gomes, SA; Mundim, IM; Pianetti, GA; Santana E Silva Cardoso, FF; Souza Teixeira, L | 1 |
| Jančić Stojanović, B; Malenović, A; Stamenković, I; Vemić, A | 1 |
| Ha, PT; Hauta-Aho, T; Hoogmartens, J; Roets, E; Van Schepdael, A | 1 |
| Bergström, M; Eriksson, B; Långström, B; Lu, L; Oberg, K; Orlefors, H; Sundin, A | 1 |
| Safavi, A; Tohidi, M | 1 |
| Brichac, J; Honzatko, A; Picklo, MJ | 1 |
| Hossain, MA; Weiner, N | 1 |
| Bowes, SG; Charlett, A; Dobbs, RJ; Dobbs, SM; Hunt, WB; Kirollos, C; Kosik, R; Mozol, K; Nicholson, PW; O'Neill, CJ; Purkiss, AG; Weller, C | 1 |
| August, TF; Bayne, WF; Eisenhandler, R; Musson, DG; Titus, DC; Yeh, KC | 1 |
3 trial(s) available for carbidopa and Sensitivity and Specificity
| Article | Year |
|---|---|
Responsiveness of motor and nonmotor symptoms of Parkinson disease to dopaminergic therapy.
Topics: Activities of Daily Living; Behavioral Symptoms; Carbidopa; Disability Evaluation; Dopamine Agents; Female; Humans; Levodopa; Male; Motor Activity; Outcome Assessment, Health Care; Parkinson Disease; Sensitivity and Specificity; Severity of Illness Index; Surveys and Questionnaires | 2010 |
Carbidopa pretreatment improves image interpretation and visualisation of carcinoid tumours with 11C-5-hydroxytryptophan positron emission tomography.
Topics: 5-Hydroxytryptophan; Carbidopa; Carbon Radioisotopes; Carcinoid Tumor; Female; Humans; Image Enhancement; Liver Neoplasms; Lymphatic Metastasis; Male; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2006 |
Objective measurement of activation of rigidity: diagnostic, pathogenetic and therapeutic implications in parkinsonism.
Topics: Adult; Aged; Antiparkinson Agents; Carbidopa; Delayed-Action Preparations; Drug Combinations; Female; Hand Strength; Humans; Isometric Contraction; Levodopa; Male; Muscle Rigidity; Parkinson Disease; Physical Exertion; Reproducibility of Results; Sensitivity and Specificity; Torque; Trihexyphenidyl | 1996 |
17 other study(ies) available for carbidopa and Sensitivity and Specificity
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Which Scale Best Detects Treatment Response of Tremor in Parkinsonism?
Topics: Adult; Aged; Antiparkinson Agents; Carbidopa; Deep Brain Stimulation; Drug Combinations; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Outcome Assessment, Health Care; Parkinsonian Disorders; Sensitivity and Specificity; Severity of Illness Index; Tremor | 2020 |
Sensitivity improvement of the LC-MS/MS quantification of carbidopa in human plasma and urine by derivatization with 2,4-pentanedione.
Topics: Carbidopa; Chromatography, Liquid; Humans; Pentanones; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry | 2017 |
Motor matters: tackling heterogeneity of Parkinson's disease in functional MRI studies.
Topics: Antiparkinson Agents; Basal Ganglia; Carbidopa; Disability Evaluation; Humans; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Parkinson Disease; Psychomotor Performance; Reproducibility of Results; Sensitivity and Specificity; Severity of Illness Index | 2013 |
[(11)C]5-HTP and microPET are not suitable for pharmacodynamic studies in the rodent brain.
Topics: 5-Hydroxytryptophan; Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Brain; Carbidopa; Carbon Radioisotopes; Enzyme Inhibitors; Hydrazines; Male; Models, Biological; Positron-Emission Tomography; Rats; Rats, Wistar; Sensitivity and Specificity; Serotonin; Tissue Distribution; Tryptophan | 2014 |
A new HILIC-MS/MS method for the simultaneous analysis of carbidopa, levodopa, and its metabolites in human plasma.
Topics: Aged; Antiparkinson Agents; Carbidopa; Chromatography, Liquid; Drug Monitoring; Drug Stability; Female; Humans; Hydrophobic and Hydrophilic Interactions; Levodopa; Linear Models; Male; Middle Aged; Parkinson Disease; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry | 2014 |
Sensitive determination of carbidopa through the electrochemiluminescence of luminol at graphene-modified electrodes.
Topics: Biosensing Techniques; Carbidopa; Electrochemistry; Electrodes; Equipment Design; Gold; Graphite; Humans; Hydrogen-Ion Concentration; Limit of Detection; Luminescent Measurements; Luminol; Reproducibility of Results; Sensitivity and Specificity | 2015 |
Towards an expert system for accurate diagnosis and progress monitoring of Parkinson's disease.
Topics: Algorithms; Antiparkinson Agents; Biomarkers; Carbidopa; Deep Brain Stimulation; Disease Progression; Drug Therapy, Combination; Expert Systems; Humans; Levodopa; Parkinson Disease; Sensitivity and Specificity | 2015 |
Effect of Carbidopa on 18F-FDOPA Uptake in Insulinoma: From Cell Culture to Small-Animal PET Imaging.
Topics: Animals; Carbidopa; Cell Line, Tumor; Dihydroxyphenylalanine; Female; Image Enhancement; Insulinoma; Metabolic Clearance Rate; Mice, Nude; Organ Specificity; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution | 2017 |
Simultaneous determination of levodopa and carbidopa by synchronous fluorescence spectrometry using double scans.
Topics: Carbidopa; Levodopa; Pharmaceutical Preparations; Sensitivity and Specificity; Spectrometry, Fluorescence; Time Factors | 2008 |
Development and validation of a high-performance liquid chromatography-electrospray ionization-MS/MS method for the simultaneous quantitation of levodopa and carbidopa in human plasma.
Topics: Administration, Oral; Carbidopa; Chromatography, High Pressure Liquid; Drug Stability; Female; Humans; Levodopa; Male; Methyldopa; Reproducibility of Results; Sensitivity and Specificity; Tablets; Tandem Mass Spectrometry | 2011 |
Chaotropic agents in liquid chromatographic method development for the simultaneous analysis of levodopa, carbidopa, entacapone and their impurities.
Topics: Antiparkinson Agents; Carbidopa; Catechols; Chromatography, Reverse-Phase; Drug Contamination; Levodopa; Nitriles; Particle Size; Reproducibility of Results; Sensitivity and Specificity; Trifluoroacetic Acid | 2013 |
Simultaneous determination of dopa and carbidopa enantiomers by capillary zone electrophoresis.
Topics: Carbidopa; Cyclodextrins; Dihydroxyphenylalanine; Electrophoresis, Capillary; Hydrogen-Ion Concentration; Reproducibility of Results; Sensitivity and Specificity; Stereoisomerism | 2002 |
Simultaneous kinetic determination of levodopa and carbidopa by H-point standard addition method.
Topics: Antiparkinson Agents; Carbidopa; Ethanol; Excipients; Hydrogen-Ion Concentration; Kinetics; Levodopa; Osmolar Concentration; Oxidation-Reduction; Pharmaceutical Preparations; Phenanthrolines; Sensitivity and Specificity; Solubility; Spectrophotometry; Surface-Active Agents; Tablets; Temperature | 2007 |
Quantification of trans-4-hydroxy-2-nonenal enantiomers and metabolites by LC-ESI-MS/MS.
Topics: Aldehydes; Alzheimer Disease; Animals; Biomarkers; Brain; Carbidopa; Chromatography, High Pressure Liquid; Glutathione; Lipid Peroxidation; Male; Mitochondria; Molecular Structure; Oxidation-Reduction; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Sensitivity and Specificity; Specimen Handling; Spectrometry, Mass, Electrospray Ionization; Spectrophotometry, Ultraviolet; Stereoisomerism; Tandem Mass Spectrometry | 2007 |
Dopaminergic functional supersensitivity: effects of chronic L-dopa and carbidopa treatment in an animal model of Parkinson's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Biopterins; Brain Diseases; Carbidopa; Corpus Striatum; Cyclic AMP; Disease Models, Animal; Dopamine; Dopamine D2 Receptor Antagonists; Homovanillic Acid; Levodopa; Male; Oxidopamine; Parkinson Disease; Rats; Rats, Inbred F344; Receptors, Dopamine D1; Receptors, Dopamine D2; Sensitivity and Specificity; Substantia Nigra; Time Factors | 1993 |
Simultaneous high-performance liquid chromatographic analysis of carbidopa, levodopa and 3-O-methyldopa in plasma and carbidopa, levodopa and dopamine in urine using electrochemical detection.
Topics: Carbidopa; Chromatography, High Pressure Liquid; Dopamine; Electrochemistry; Humans; Levodopa; Reproducibility of Results; Sensitivity and Specificity; Tyrosine | 1990 |